Kura Oncology Reports Inducement Stock Option Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology has reported inducement grants under Nasdaq Listing Rule 5635(c)(4), granting non-statutory stock options to purchase 69,750 shares of common stock to four new employees. Each stock option has an exercise price of $8.27 per share and will vest over four years. The grants are part of the company's 2023 Inducement Option Plan, as amended.